| Year |
Citation |
Score |
| 2017 |
Wang Q, Barry MA, Seid CA, Hudspeth EM, McAtee CP, Heffernan MJ. 3M-052 as an adjuvant for a PLGA microparticle-based Leishmania donovani recombinant protein vaccine. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. PMID 28804955 DOI: 10.1002/Jbm.B.33965 |
0.367 |
|
| 2016 |
Barry MA, Wang Q, Jones KM, Heffernan MJ, Buhaya MH, Beaumier CM, Keegan BP, Zhan B, Dumonteil E, Bottazzi ME, Hotez PJ. A therapeutic nanoparticle vaccine against Trypanosoma cruzi in a BALB/c mouse model of Chagas disease. Human Vaccines & Immunotherapeutics. 0. PMID 26890466 DOI: 10.1080/21645515.2015.1119346 |
0.441 |
|
| 2016 |
Hudspeth EM, Wang Q, Seid CA, Hammond M, Wei J, Liu Z, Zhan B, Pollet J, Heffernan MJ, McAtee CP, Engler DA, Matsunami RK, Strych U, Asojo OA, Hotez PJ, et al. Expression and Purification of an Engineered, Yeast-expressed Leishmania donovani Nucleoside Hydrolase with Immunogenic Properties. Human Vaccines & Immunotherapeutics. 0. PMID 26839079 DOI: 10.1080/21645515.2016.1139254 |
0.353 |
|
| 2014 |
Wang Q, Tan MT, Keegan BP, Barry MA, Heffernan MJ. Time course study of the antigen-specific immune response to a PLGA microparticle vaccine formulation. Biomaterials. 35: 8385-93. PMID 24986256 DOI: 10.1016/J.Biomaterials.2014.05.067 |
0.397 |
|
| 2013 |
Hotez PJ, Dumonteil E, Heffernan MJ, Bottazzi ME. Innovation for the 'bottom 100 million': eliminating neglected tropical diseases in the Americas. Advances in Experimental Medicine and Biology. 764: 1-12. PMID 23654053 DOI: 10.1007/978-1-4614-4726-9_1 |
0.349 |
|
| 2012 |
Dumonteil E, Bottazzi ME, Zhan B, Heffernan MJ, Jones K, Valenzuela JG, Kamhawi S, Ortega J, Rosales SP, Lee BY, Bacon KM, Fleischer B, Slingsby BT, Cravioto MB, Tapia-Conyer R, et al. Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospects. Expert Review of Vaccines. 11: 1043-55. PMID 23151163 DOI: 10.1586/Erv.12.85 |
0.367 |
|
| 2011 |
Heffernan MJ, Zaharoff DA, Fallon JK, Schlom J, Greiner JW. In vivo efficacy of a chitosan/IL-12 adjuvant system for protein-based vaccines. Biomaterials. 32: 926-32. PMID 20965561 DOI: 10.1016/J.Biomaterials.2010.09.058 |
0.372 |
|
| 2009 |
Heffernan MJ, Murthy N. Disulfide-crosslinked polyion micelles for delivery of protein therapeutics. Annals of Biomedical Engineering. 37: 1993-2002. PMID 19513846 DOI: 10.1007/S10439-009-9734-X |
0.543 |
|
| 2009 |
Heffernan MJ, Kasturi SP, Yang SC, Pulendran B, Murthy N. The stimulation of CD8+ T cells by dendritic cells pulsed with polyketal microparticles containing ion-paired protein antigen and poly(inosinic acid)-poly(cytidylic acid). Biomaterials. 30: 910-8. PMID 19036430 DOI: 10.1016/J.Biomaterials.2008.10.034 |
0.559 |
|
| 2007 |
Lee S, Yang SC, Heffernan MJ, Taylor WR, Murthy N. Polyketal microparticles: a new delivery vehicle for superoxide dismutase. Bioconjugate Chemistry. 18: 4-7. PMID 17226951 DOI: 10.1021/Bc060259S |
0.556 |
|
| 2005 |
Heffernan MJ, Murthy N. Polyketal nanoparticles: a new pH-sensitive biodegradable drug delivery vehicle. Bioconjugate Chemistry. 16: 1340-2. PMID 16287226 DOI: 10.1021/Bc050176W |
0.536 |
|
| Show low-probability matches. |